Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cancer stem cells can be therapeutic target.

Share :

EBCC 6 2008

15 - 19 Apr 2008
Published: 3 Dec 2008
Views: 15854
Rating:
Save
Dr. Angel Rodriguez
New drug shrinks breast cancer tumours significantly in just six weeks research shows that cancer stem cells can be therapeutic target.

Related Videos

ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA
Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )
12 Jul 2024
Antibody drug conjugates coming to primetime and new agents for breast cancer
Dr Mariana Chavez McGregor - MD Anderson Cancer Center, Houston, USA
Antibody drug conjugates coming to primetime and new agents for breast cancer ( Dr Mariana Chavez McGregor - MD Anderson Cancer Center, Houston, USA )
12 Jul 2024
Intervention of osteoclastogenesis that occurs in breast cancer and multiple...
Dr Gregg Fields - Florida Atlantic University, Florida, USA
Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )
12 Jul 2024
Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced...
Dr Kevin Kalinsky - Winship Cancer Institute, Georgia, USA
Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared to placebo and fulvestrant ( Dr Kevin Kalinsky - Winship Cancer Institute, Georgia, USA )
26 Jun 2024
Addition of atezolizumab to chemotherapy after surgery does not improve...
Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )
26 Apr 2024
EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation